New publication in npj Vaccines from C2i's Managing Director Professor Leo Poon's team describing an innovative approach to developing a live attenuated SARS-CoV-2 vaccine candidate. The study demonstrates a novel approach to engineering a highly attenuated yet fully immunogenic SARS-CoV-2 vaccine candidate, showing: Near-sterile immunity in mice under stringent challenge conditions Broad protection against antigenically distinct variants and even SARS-CoV Complete block of o

Congratulations to our spin-off company C2iTech Limited for making the Top 5 of the EQT Impact Challenge Hong Kong 2026! C2iTech has officially reached the Top 5 of the EQT Impact Challenge Hong Kong 2026! Our innovative flight simulator for human respiratory drug response is changing the game. Support our journey to the Grand Finale — vote by 26 August: https://eqtimpactchallenge2026.scmp.com/